BOSTON, Feb. 23, 2026 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), a clinical stage company pioneering immuno-oncology and RNA therapeutics for the treatment of high risk and advanced cancers, today announced the publication of a manuscript titled Template-Directed RIG-I...
Hence then, the article about transcode therapeutics announces publication of preclinical testing of rig i immunotherapeutic candidate supporting further development was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( TransCode Therapeutics Announces Publication of Preclinical Testing of RIG-I Immunotherapeutic Candidate Supporting Further Development )
Also on site :
- ‘Tournament of Champions’ Season 7 Bracket Revealed: Here Are the Official Matchups
- Person injured in apartment fire in Irvine
- Masonite International Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - DOOR